The United States is the world leader in creating lifesaving medical devices, but can we get even better at it? The U.S. Food and Drug Administration is seeking ideas on how it might be able to enhance the process of identifying serious unmet public health needs and then developing devices to help resolve them. The agency sent out a release today about a daylong workshop it's holding on June 24 to explore this subject at the Hilton Hotel in Gaithersburg, Md. Although the event is open to the public, seating is limited. It isn't being webcast or videotaped.
Among the speakers are several with connections to Silicon Valley, including Bonnie Norman of Intel Corp.; David Klonoff, the medical director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Health Services in San Mateo, Calif.; and Jack W. Lasersohn, a member of the board of directors of the National Venture Capital Association and a founding general partner of the Vertical Group, a firm with offices in Palo Alto and Summit, N.J.
